Health
New drug regimen is safe and effective in children with cystic fibrosis – News-Medical.Net
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, found that a regimen of three…
An international, open-label Phase 3 study, co-led by Susanna McColley, MD, from Ann & Robert H. Lurie Children’s Hospital of Chicago, found that a regimen of three drugs (elexacaftor/tezacaftor/ivacaftor) that targets the genetic cause of cystic fibrosis was safe and effective in 6-11-year-olds with at least one copy of F508del mutation in the CFTR gene, which is estimated to represent almost 90 percent of the cystic fibrosis population in the United States.
For children in this age group who have…
-
Business23 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Business24 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News23 hours agoDid AI write your accounting expert’s report? – Proctor
-
Noosa News23 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane